Cargando…

Effects of Childhood Multidisciplinary Care and Growth Hormone Treatment on Health Problems in Adults with Prader-Willi Syndrome

Prader-Willi syndrome (PWS) is a complex hypothalamic disorder. Features of PWS include hyperphagia, hypotonia, intellectual disability, and pituitary hormone deficiencies. The combination of growth hormone treatment and multidisciplinary care (GHMDc) has greatly improved the health of children with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pellikaan, Karlijn, Rosenberg, Anna G. W., Davidse, Kirsten, Kattentidt-Mouravieva, Anja A., Kersseboom, Rogier, Bos-Roubos, Anja G., Grootjen, Lionne N., Damen, Layla, van den Berg, Sjoerd A. A., van der Lely, Aart J., Hokken-Koelega, Anita C. S., de Graaff, Laura C. G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347981/ https://www.ncbi.nlm.nih.gov/pubmed/34362034 http://dx.doi.org/10.3390/jcm10153250

Ejemplares similares

Missed Diagnoses and Health Problems in Adults With Prader-Willi Syndrome: Recommendations for Screening and Treatment
por: Pellikaan, Karlijn, et al.
Publicado: (2020)

Prenatal and Neonatal Characteristics of Children with Prader-Willi Syndrome
por: Grootjen, Lionne N., et al.
Publicado: (2022)

SAT-446 No Central Adrenal Insufficiency Found in Adults with Prader-Willi Syndrome Tested by Multiple-Dose Metyrapone Test
por: Davidse, Kirsten, et al.
Publicado: (2019)

Thyroid Function in Adults with Prader–Willi Syndrome; a Cohort Study and Literature Review
por: Pellikaan, Karlijn, et al.
Publicado: (2021)

Atypical 15q11.2-q13 Deletions and the Prader-Willi Phenotype
por: Grootjen, Lionne N., et al.
Publicado: (2022)

MON-284 Systematic Screening Reveals Large Number of Undiagnosed and Untreated Cardiovascular Risk Factors in Adults with Prader-Willi Syndrome
por: Pellikaan, Karlijn, et al.
Publicado: (2020)

Oxytocin in young children with Prader‐Willi syndrome: Results of a randomized, double‐blind, placebo‐controlled, crossover trial investigating 3 months of oxytocin
por: Damen, Layla, et al.
Publicado: (2020)

Acute stress response of the HPA-axis in children with Prader-Willi syndrome: new insights and consequences for clinical practice
por: Grootjen, Lionne N., et al.
Publicado: (2023)

Central Adrenal Insufficiency Is Rare in Adults With Prader–Willi Syndrome
por: Rosenberg, Anna G W, et al.
Publicado: (2020)

Growth Hormone Treatment for Adults With Prader-Willi Syndrome: A Meta-Analysis
por: Rosenberg, Anna G W, et al.
Publicado: (2021)

Computer-aided facial analysis as a tool to identify patients with Silver–Russell syndrome and Prader–Willi syndrome
por: Ciancia, Silvia, et al.
Publicado: (2023)

What Every Internist-Endocrinologist Should Know about Rare Genetic Syndromes in Order to Prevent Needless Diagnostics, Missed Diagnoses and Medical Complications: Five Years of ‘Internal Medicine for Rare Genetic Syndromes’
por: Rosenberg, Anna G. W., et al.
Publicado: (2021)

SUN-308 Central Adrenal Insufficiency Is Rare in Adults with Prader-Willi Syndrome
por: Rosenberg, Anna G W, et al.
Publicado: (2020)

Kidney disease in adults with Prader-Willi syndrome: international cohort study and systematic literature review
por: van Abswoude, Denise H., et al.
Publicado: (2023)

Health Problems in Adults with Prader–Willi Syndrome of Different Genetic Subtypes: Cohort Study, Meta-Analysis and Review of the Literature
por: Rosenberg, Anna G. W., et al.
Publicado: (2022)

Hyperprolactinemia in Adults with Prader-Willi Syndrome
por: Sjöström, Anna, et al.
Publicado: (2021)

Three years of growth hormone treatment in young adults with Prader-Willi syndrome: sustained positive effects on body composition
por: Damen, Layla, et al.
Publicado: (2020)

RF17 | PMON27 Genetic Subtype Differences in Relation to Health Problems Among Adults With Prader-Willi Syndrome
por: Pellikaan, Karlijn, et al.
Publicado: (2022)

What Every Internist Should Know About Rare Genetic Syndromes in Order to Prevent Needless Diagnostics, Missed Diagnoses and Medical Complications: Five-Year Experience of Internal Medicine for Complex Rare Genetic Syndromes
por: Rosenberg, Anna G W, et al.
Publicado: (2021)

Evidence for Accelerated Biological Aging in Young Adults with Prader–Willi Syndrome
por: Donze, Stephany H, et al.
Publicado: (2019)

Bone Health in Adults With Prader–Willi Syndrome: Clinical Recommendations Based on a Multicenter Cohort Study
por: van Abswoude, Denise H, et al.
Publicado: (2022)

What endocrinologists can do to prevent cardiovascular complications in adults with Prader-Willi syndrome: Lessons from a case series
por: Pellikaan, Karlijn, et al.
Publicado: (2023)

OR27-5 Malignancies in Prader-Willi Syndrome: Practical Recommendations Based on a Large International Cohort
por: Caixàs, Assumpta, et al.
Publicado: (2022)

Family Matters: Trauma and Quality of Life in Family Members of Individuals With Prader-Willi Syndrome
por: Bos-Roubos, Anja, et al.
Publicado: (2022)

Transition readiness among adolescents with rare endocrine conditions
por: van Alewijk, Lisette, et al.
Publicado: (2021)

Malignancies in Prader-Willi Syndrome: Results From a Large International Cohort and Literature Review
por: Pellikaan, Karlijn, et al.
Publicado: (2023)

Hypogonadism in Adult Males with Prader-Willi Syndrome—Clinical Recommendations Based on a Dutch Cohort Study, Review of the Literature and an International Expert Panel Discussion
por: Pellikaan, Karlijn, et al.
Publicado: (2021)

Hypogonadism in Women with Prader-Willi Syndrome—Clinical Recommendations Based on a Dutch Cohort Study, Review of the Literature and an International Expert Panel Discussion
por: Pellikaan, Karlijn, et al.
Publicado: (2021)

Prevalence of growth hormone (GH) deficiency in previously GH‐treated young adults with Prader‐Willi syndrome
por: Donze, Stephany H., et al.
Publicado: (2019)

SUN-080 We Mind Your Step: Understanding and Preventing Drop-Out in the Transition from Paediatric to Adult Tertiary Endocrine Healthcare
por: Davidse, Kirsten, et al.
Publicado: (2020)

A Transcriptomic Signature of the Hypothalamic Response to Fasting and BDNF Deficiency in Prader-Willi Syndrome
por: Bochukova, Elena G., et al.
Publicado: (2018)

Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader–Willi syndrome
por: Kuppens, R. J., et al.
Publicado: (2015)

The Diagnostic Journey of a Patient with Prader–Willi-Like Syndrome and a Unique Homozygous SNURF-SNRPN Variant; Bio-Molecular Analysis and Review of the Literature
por: Pellikaan, Karlijn, et al.
Publicado: (2021)

Reduced Cortical Complexity in Children with Prader-Willi Syndrome and Its Association with Cognitive Impairment and Developmental Delay
por: Lukoshe, Akvile, et al.
Publicado: (2014)

Long-Term Growth Hormone Treatment of Children with PWS: The Earlier the Start, the Better the Outcomes?
por: Grootjen, Lionne N., et al.
Publicado: (2022)

Appetite- and weight-inducing and -inhibiting neuroendocrine factors in Prader–Willi syndrome, Bardet–Biedl syndrome and craniopharyngioma versus anorexia nervosa
por: Vlaardingerbroek, H, et al.
Publicado: (2021)

Hyponatremia in Children and Adults with Prader–Willi Syndrome: A Survey Involving Seven Countries
por: Coupaye, Muriel, et al.
Publicado: (2021)

Divergent structural brain abnormalities between different genetic subtypes of children with Prader–Willi syndrome
por: Lukoshe, Akvile, et al.
Publicado: (2013)

THU171 Reference Intervals For Bioavailable IGF-I Values In Dutch Healthy Children, Adolescents And Young Adults
por: Pellikaan, Karlijn, et al.
Publicado: (2023)

We mind your step: understanding and preventing drop-out in the transfer from paediatric to adult tertiary endocrine healthcare
por: Davidse, Kirsten, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a93gn53iej235v2npvrd74d1n6